445Epidemiology and Outcomes of Clostridium difficile Infections in Heart and Heart-lung Transplant Recipients
نویسندگان
چکیده
Background. Clostridium difficileinfection (CDI) is an important cause of diarrhea in transplant recipients, and often complicated by the use of intense immunosuppression and need for antibiotic prophylaxis. We aimed to investigate the epidemiology of CDI in heart and heart-lung transplant (HT) recipients and assessed its impact on outcomes. Methods. This is a retrospective study of HT recipients from 2000 to 2013. CDI was defined by presence of diarrhea and a positive toxigenic Clostridium difficilein stool measured by toxin enzyme immunoassay (EIA) (2000-2006) or polymerase chain reaction (2007-2013). Survival was assessed using Kaplan-Meier method. The hazard ratio (HR) for all-cause mortality was calculated using Cox proportional hazard model. Results. A total of 322 HT recipients were at risk during the 14-year study period. The median age was 53 years (IQR, 44-60); 66 % were male. During the median followup of 49 months (IQR, 1995), 27 (8.4%) patients developed CDI after transplant. Of those, six (28.5%) developed CDI within 30 days of transplant, while 21 (71.5%) patients developed CDI beyond 30 days from transplant. Two (7.4%) had hypervirulent NAP1/BI/027 strain. Six (22%) had at least 1 episode of recurrent CDI. No patient required colectomy or died from CDI. However, patients with CDI had worse overall survival compared to non-CDI patients (log rank test; p < 0.01) (Figure 1).In univariate analysis, the predictors of mortality in HT recipients were: CDI anytime after transplant [HR 2.33; 95% CI, 1.14-4.32 (p = 0.02)], female donor [HR 1.83; 95% CI, 1.09-3.03 (p = 0.02)], older donor age per 1 year increase [HR 1.05; 95% CI, 0.99-1.03 (p = 0.09)] and combined heart-lung transplant [HR 2.13; 95% CI, 0.82-4.60 (p = 0.11)].In a multivariate analysis, CDI anytime after transplant remained significantly associated with all-cause mortality [HR 2.23; 95% CI, 1.07-4.27 (p = 0.03)]. Conclusion. CDI is a common cause of diarrhea in HT patients. CDI is significantly associated with, and an independent predictor for, increased mortality after heart transplantation. Efforts to prevent CDI may improve survival of HT recipients. Disclosures. All authors: No reported disclosures.
منابع مشابه
Rituximab Is Indispensable for Pediatric Heart Transplant Recipients Developing Post transplant Lymphoproliferative Disorders
Abstract Rituximab, an anti-CD20 agent, has been suggested as an effective strategy to deal with post transplant lymphoproliferative disorders (PTLD). In the current study, we aim to evaluate the efficacy of rituximab therapy in heart transplant population developing PTLD. A comprehensive search of the literature was performed to gather the available data on lymphoproliferative disorders oc...
متن کاملLoss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant
We report the use of fecal microbiota transplantation in a single heart-kidney transplant recipient with recurrent Clostridium difficile, vancomycin-resistant Enterococcus (VRE) fecal dominance, and recurrent VRE infections. Fecal microbiota transplantation resulted in the reconstruction of a diverse microbiota with (1) reduced relative abundance of C difficile and VRE and (2) positive clinical...
متن کاملCytomegalovirus infections in heart and heart-lung transplant recipients.
Of the first 250 heart and 41 heart-lung transplant recipients in the Papworth series, 244 who survived for longer than one month after transplantation were studied for evidence of cytomegalovirus (CMV) infection by serological methods. Overall, 43 (17.6%) patients acquired primary CMV infection and 76 (31.1%) had evidence of CMV reactivation or reinfection. The source of CMV infection was foun...
متن کاملPrevalence of Clostridium difficile Infection among Solid Organ Transplant Recipients: A Meta-Analysis of Published Studies
Several factors including antibiotic use, immunosuppression and frequent hospitalizations make solid organ transplant (SOT) recipients vulnerable to Clostridium difficile infection (CDI). We conducted a meta-analysis of published studies from 1991-2014 to estimate the prevalence of CDI in this patient population. We searched PubMed, EMBASE and Google Scholar databases. Among the 75,940 retrieve...
متن کاملFungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.
OBJECTIVES Heart and lung transplant recipients are at risk for invasive fungal infections. This study evaluated the affect of single-agent antifungal prophylaxis with itraconazole on the rate of fungal infections after heart or lung transplant. MATERIALS AND METHODS An observational, retrospective study was performed to evaluate the rate of fungal infections in heart and lung transplant reci...
متن کامل